NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Medicines

Latest News & Postscripts

Wound management products update

Posted: January 18, 2016.
Category - Medicines Update
Tagged with - Wounds Antimicrobial Prescribing

The updated Wound Management Formulary (December 2015) is now available. This provides not only a list of approved products for acute and primar...

Read More...

Genuair inhalers: potential safety issue

Posted: January 18, 2016.
Category - Medicines Update
Tagged with - Respiratory

Unlike many inhalers, the dose counter for Duaklir® (aclidinium/formoterol) and Eklira® (aclidinium) Genuair® products reduce in intervals of 10 inhalations: 60, 50, 40, 30, 20, 10, 0.   We have...

Read More...

Denosumab shared care for osteoporosis

Posted: January 18, 2016.
Category - Medicines Update
Tagged with - Osteoporosis

Denosumab 60mg/1mL is a second line drug used in the treatment of osteoporosis to reduce the risk of hip, vertebral and non-vertebral fractures. It is admi...

Read More...

Anticoagulants and dental procedures

Posted: January 18, 2016.
Category - Medicines Update
Tagged with - Dabigatran Anticoagulants Antiplatelets

Anticoagulants or antiplatelets for patients undergoing dental procedures New guidance on the Management of Dental Patients Taking Anticoagulants or Antiplatelet Drugs has been p...

Read More...

Ventmax and Pulvinal discontinued

Posted: January 18, 2016.
Category - Medicines Update
Tagged with - Respiratory Asthma

There are small numbers of patients using these products. Advice on switching is given below.   Ventmax® salbutamol tablets: Inhalation route preferred for salbutamol.

Read More...

Insuman insulin shortage

Posted: January 18, 2016.
Category - Medicines Update
Tagged with - Diabetes

Sanofi have announced there will be a temporary and short-term supply shortage of Insuman® Basal pre-filled pens Insuman® Basal cartridges Insuman® Comb25 (pre-mixed insulin) pre-filled pens.

Read More...

Prescribing in Myasthenia Gravis

Posted: January 13, 2016.
Category - Medicines Update Acute
Tagged with - Pyridostigmine gentamicin

Prescribing in Myasthenia Gravis Key messages • Delay or omission of Myasthenia Gravis (MG) medicines can very quickly result in a significant worsening of the patient’s myasthen...

Read More...

Twitter and Facebook

Posted: December 28, 2015.
Category - Medicines Update

Twitter: follow us at @NHSGGCMeds or search the hashtag #ggcmedicines Facebook: search and like NHSGGC Medicines Update.   NHSGGC Medicin...

Read More...

MUE 04: PPIs

Posted: December 18, 2015.
Category - Medicines Update Extra

 Oral Proton Pump Inhibitors

  • Proton Pump Inhibitors (PPIs) are one of the most commonly prescribed classes of drug
  • PPIs are an effective treatment when used appropriately
  • PPIs should only be prescribed where there is a clear indication
  • PPIs are usually well tolerated
  • Recent evidence suggests that PPIs may have potentially serious adverse effects such as fractures, hypomagnesaemia, subacute cutaneous lupus erythematosus, pneumonia and Clostridium difficile infection

Read More...

Shared Care Protocols

Posted: December 17, 2015.
Category - Medicines Update

The Prescribing Interface Subcommittee of the Area Drug & Therapeutics Committee (ADTC) co-ordinates the formal management of prescribing issues between primary care and the acute setting including the review, approval and collation of Shar...

Read More...